2013 Articles

2013 Articles

  • Bechara EG, Sebestyén E, Bernardis I, Eyras E, Valcárcel J. RBM5, 6, and 10 Differentially Regulate NUMB Alternative Splicing to Control Cancer Cell Proliferation. Molecular Cell 2013; 52:720-733 FI: 15.280 Q1.
  • Ramos M, Boada L, Moreno C, Llorente C, Romo J, Parellada M. Attitude and risk of substance use in adolescents diagnosed with Asperger syndrome. Drug and Alcohol Dependence 2013;133:535-540 FI: 3.141 Q2.
  • Bioque M, García-Bueno B, Macdowell KS, Meseguer A, Saiz PA, Parellada M, Gonzalez-Pinto A, Rodriguez-Jimenez R, Lobo A, Leza JC, Bernardo M; FLAMM-PEPs study—Centro de Investigación Biomédica en Red de Salud Mental. Peripheral Endocannabinoid System Dysregulation in First-Episode Psychosis. Neuropsychopharmacology 2013; 38: 2568-2577  FI: 8.678 Q1.
  • Camacho-Garcia RJ, Hervás A, Toma C, Balmaña N, Cormand B, Martinez-Mir A, Scholl FG. Rare variants analysis of neurexin-1 beta in autism reveals a novel start codon mutation affecting protein levels at synapses. Psychiatric Genetics 2013; 23: 262-266  FI: 2.365 Q3.
  • Inostroza M, Brotons-Mas JR, Laurent F, Cid E, de la Prida LM. Specific Impairment of «What-Where-When» Episodic-Like Memory in Experimental Models of Temporal Lobe Epilepsy. Journal of Neuroscience 2013; 33:17749-17762 FI: 6.908 Q1.
  • Arango C, Garibaldi G, Marder SR. Pharmacological approaches to treating negative symptoms: A review of clinical trials. Schizophrenia Research 2013; 150:346-352  FI: 4.590 Q1.
  • Dominguez MD, Fisher HL, Major B, Chisholm B, Rahaman N, Joyce J, Woolley J, Lawrence J, Hinton M, Marlowe K, Aitchison K, Johnson S, Hodes M. Duration of untreated psychosis in adolescents: Ethnic differences and clinical profiles. Schizophrenia Research 2013; 150: 526-532 FI: 4.590 Q1.
  • Gilabert-Juan J, Belles M, Saez AR, Carceller H, Zamarbide-Fores S, Moltó MD, Nacher J.   A «double hit» murine model for schizophrenia shows alterations in the structure and neurochemistry of the medial prefrontal cortex and the hippocampus. Neurobiology of Disease 2013; 59:126-140  FI: 5.624 Q1.
  • Moreno M, Sáenz-Cuesta M, Castilló J, Cantó E, Negrotto L, Vidal-Jordana A, Montalban X, Comabella M. Circulating levels of soluble apoptosis-related molecules in patients with multiple sclerosis.  Journal of Neuroimmunology 2013; 263:152-154  FI: 3.033 Q2.
  • González-Aramburu I, Sánchez-Juan P, Jesús S, Gorostidi A, Fernández-Juan E, Carrillo F, Sierra M, Gómez-Garre P, Cáceres-Redondo MT, Berciano J, Ruiz-Martínez J, Combarros O, Mir P, Infante J. Genetic Variability Related to Serum Uric Acid Concentration and Risk of Parkinson’s Disease.  Movement Disorders 2013; 28:1737-1740 FI: 4.558 Q1.
  • Moreno C, Nuevo R, Chatterji S, Verdes E, Arango C, Ayuso-Mateos JL. Psychotic symptoms are associated with physical health problems independently of a mental disorder diagnosis: results from the WHO World Health Survey. World Psychiatry 2013; 12:251-257  FI: 8.974 Q1.
  • De la Cruz LF, Micali N, Roberts S, Turner C, Nakatani E, Heyman I, Mataix-Cols D. Are the symptoms of obsessive-compulsive disorder temporally stable in children/adolescents? A prospective naturalistic study. Psychiatry Research 2013; 209:196-201  FI: 2.456 Q2.
  • Alemán-Gómez Y, Janssen J, Schnack H, Balaban E, Pina-Camacho L, Alfaro-Almagro F, Castro-Fornieles J, Otero S, Baeza I, Moreno D, Bargalló N, Parellada M, Arango C, Desco M. The Human Cerebral Cortex Flattens during Adolescence. Journal of Neuroscience 2013; 33:15004-15010  FI: 6.908 Q1.
  • Santos M, D’Amico D, Spadoni O, Amador-Arjona A, Stork O, Dierssen M. Hippocampal Hyperexcitability Underlies Enhanced Fear Memories in TgNTRK3, a Panic Disorder Mouse Model. Journal of Neuroscience 2013; 33:15259-15271 FI: 6.908 Q1.
  • Toma C, Hervás A, Balmaña N, Salgado M, Maristany M, Vilella E, Aguilera F, Orejuela C, Cuscó I, Gallastegui F, Pérez-Jurado LA, Caballero-Andaluz R, Diego-Otero Yd, Guzmán-Alvarez G, Ramos-Quiroga JA, Ribasés M, Bayés M, Cormand B. Neurotransmitter systems and neurotrophic factors in autism: association study of 37 genes suggests involvement of DDC. World Journal of Biological Psychiatry 2013; 14: 516-527 FI: 3.571 Q1.
  • Jesús S, Gómez-Garre P, Carrillo F, Cáceres-Redondo MT, Huertas-Fernández I, Bernal-Bernal I, Bonilla-Toribio M, Vargas-González L, Carballo M, Mir P. Genetic association of sirtuin genes and Parkinson’s disease. Journal of Neurology 2013; 260:2237-2241 FI: 3.578 Q1.
  • Sanchez-Cao E, Kramer T, Hodes M. Psychological distress and mental health service contact of unaccompanied asylum-seeking children. Child Care Health and Development 2013; 39: 651-659 FI: 1.700 Q2.
  • Vidal R, Diaz A, Pazos A, Castro E. Region-specific regulation of 5-HT1B receptors in the rat brain by chronic venlafaxine treatment. Psychopharmacology 2013; 229:177-185 FI: 4.061 Q1.
  • Torrent C, Bonnin Cdel M, Martínez-Arán A, Valle J, Amann BL, González-Pinto A, Crespo JM, Ibáñez Á, Garcia-Portilla MP, Tabarés-Seisdedos R, Arango C, Colom F, Solé B, Pacchiarotti I, Rosa AR, Ayuso-Mateos JL, Anaya C, Fernández P, Landín-Romero R, Alonso-Lana S, Ortiz-Gil J, Segura B, Barbeito S, Vega P, Fernández M, Ugarte A, Subirà M, Cerrillo E, Custal N, Menchón JM, Saiz-Ruiz J, Rodao JM, Isella S, Alegría A, Al-Halabi S, Bobes J, Galván G, Saiz PA, Balanzá-Martínez V, Selva G, Fuentes-Durá I, Correa P, Mayoral M, Chiclana G, Merchan-Naranjo J, Rapado-Castro M, Salamero M, Vieta E. Efficacy of Functional Remediation in Bipolar Disorder: A Multicenter Randomized Controlled Study. American Journal of Psychiatry 2013; 170-852-859 FI: 14.721 Q1.
  • Fernández de la Cruz L, Barrow F, Bolhuis K, Krebs G, Volz C, Nakatani E, Heyman I, Mataix-Cols D. Sexual obsessions in pediatric obsessive-compulsive disorder: clinical characteristics and treatment outcomes. Depression and Anxiety 2013; 30:732-740  FI: 4.610 Q1.
  • Carballo JJ, García-Nieto R, Alvarez-García R, Caro-Cañizares I, López-Castromán J, Muñoz-Lorenzo L, de Leon-Martinez V, Baca-García E. Sibship size, birth order, family structure and childhood mental disorders. Social Psychiatry and Psychiatric Epidemiology 2013; 48:1327-1333 FI: 2.861 Q2.
  • González-Cabo P, Palau F. Mitochondrial pathophysiology in Friedreich’s ataxia. Journal of Neurochemistry 2013; 126-53-64 FI: 3.973 Q2.
  • Diez-Fernandez C, Martínez AI, Pekkala S, Barcelona B, Pérez-Arellano I, Guadalajara AM, Summar M, Cervera J, Rubio V. Molecular Characterization of Carbamoyl-Phosphate Synthetase (CPS1) Deficiency Using Human Recombinant CPS1 as a Key Tool. Human Mutation 2013; 34:1149-1159 FI: 5.213 Q1.
  • Ruiz-Veguilla M, Barrigón ML, Hernández L, Rubio JL, Gurpegui M, Sarramea F, Cervilla J, Gutiérrez B, James A, Ferrin M. Dose-response effect between cannabis use and psychosis liability in a non-clinical population: Evidence from a snowball sample. Journal of Psychiatric Research 2013; 47:1036-1043 FI: 4.066 Q1.
  • Carrillo F, Palomar FJ, Conde V, Diaz-Corrales FJ, Porcacchia P, Fernández-Del-Olmo M, Koch G, Mir P. Study of Cerebello-Thalamocortical Pathway by Transcranial Magnetic Stimulation in Parkinson’s Disease. Brain Stimulation 2013; 6:582-589 FI: 4.538 Q1.
  • Soutullo C, Figueroa-Quintana A. When do you Prescribe Antidepressants to Depressed Children?. Current Psychiatry Reports 2013; 15:10.1007/s11920-013-0366-3 FI: 3.230 Q2.
  • Campos AC, Ortega Z, Palazuelos J, Fogaça MV, Aguiar DC, Díaz-Alonso J, Ortega-Gutiérrez S, Vázquez-Villa H, Moreira FA, Guzmán M, Galve-Roperh I, Guimarães FS. The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system. International Journal of Neuropsychopharmacology 2013; 16:1407-1419 FI: 5.641 Q1.
  • Blasco-Fontecilla H, Jaussent I, Olié E, Garcia EB, Beziat S, Malafosse A, Guillaume S, Courtet P. Additive effects between prematurity and postnatal risk factors of suicidal behaviour. J Psychiatr Res. 2013; 47:937-493. FI: 4.066 Q1.
  • International Multiple Sclerosis Genetics Consortium, Lill CM, Schjeide BM, Graetz C, Ban M, Alcina A, Ortiz MA, Pérez J, Damotte V, Booth D, Lopez de Lapuente A, Broer L, Schilling M, Akkad DA, Aktas O, Alloza I, Antigüedad A, Arroyo R, Blaschke P, Buttmann M, Chan A, Compston A, Cournu-Rebeix I, Dörner T, Epplen JT, Fernández Ó, Gerdes LA, Guillot-Noël L, Hartung HP, Hoffjan S, Izquierdo G, Kemppinen A, Kroner A, Kubisch C, Kümpfel T, Li SC, Lindenberger U, Lohse P, Lubetzki C, Luessi F, Malhotra S, Mescheriakova J, Montalban X, Papeix C, Paredes LF, Rieckmann P, Steinhagen-Thiessen E, Winkelmann A, Zettl UK, Hintzen R, Vandenbroeck K, Stewart G, Fontaine B, Comabella M, Urcelay E, Matesanz F, Sawcer S, Bertram L, Zipp F. MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis. Brain 2013; 136: 1778-1782  FI: 9.915 Q1.
  • Guzman-Fulgencio M, Jimenez JL, Garcia-Alvarez M, Bellon JM, Fernandez-Rodriguez A, Campos Y, Rodriguez C, Gonzalez-Garcia J, Riera M, Viciana P, Munoz-Fernandez MA, Resino S. Mitochondrial Haplogroups Are Associated With Clinical Pattern of AIDS Progression in HIV-Infected Patients. JAIDS-Journal of Acquired Immune Deficiency Syndromes 2013; 63:178-183. FI: 4.653 Q1.
  • Nacher J, Guirado R, Castillo-Gómez E. Structural plasticity of interneurons in the adult brain: role of PSA-NCAM and implications for psychiatric disorders. Neurochem Res. 2013; 38:1122-1133. FI: 2.125 Q3.
  • Rodríguez-Revenga L, Vallespín E, Madrigal I, Palomares M, Mur A, García-Miñaur S, Santos F, Mori MÁ, Lapunzina P, Mila M, Nevado J.A. Parallel study of different array-CGH platforms in a set of Spanish patients with developmental delay and intellectual disability. Gene 2013; 521:82-86. FI: 2.196 Q3.
  • Baeza I, Correll CU, Saito E, Amanbekova D, Ramani M, Kapoor S, Chekuri R, De Hert M, Carbon M Frequency, Characteristics and Management of Adolescent Inpatient Aggression. Journal of Child and Adolescent Psychopharmacology 2013; 23:271-281 FI: 2.773 Q2.
  • Casas M, Rosler M, Kooij JJS, Ginsberg Y, Ramos-Quiroga JA, Heger S, Berwaerts J, Dejonckheere J, Van der Vorst E, Schauble B.Efficacy and safety of prolonged-release OROS methylphenidate in adults with attention deficit/hyperactivity disorder: A 13-week, randomized, double-blind, placebo-controlled, fixed-dose study. World Journal of Biological Psychiatry 2013; 14:268-281. FI: 3.571 Q1.
  • Kramer T, Iliffe S, Bye A, Miller L, Gledhill J, Garralda, ME. Testing the Feasibility of Therapeutic Identification of Depression in Young People in British General Practice. Journal of Adolescent Health 2013; 52:539-545. FI: 2.966 Q1.
  • Paya B, Rodriguez-Sanchez JM, Otero S, Munoz P, Castro-Fornieles J, Parellada M, Gonzalez-Pinto A; Soutullo C, Baeza I, Rapado-Castro M, Saenz-Herrero M, Moreno D, Arango C. Premorbid impairments in early-onset psychosis: Differences between patients with schizophrenia and bipolar disorder. Schizophrenia Research 2013; 146:103-110. FI: 4.590 Q1.
  • Jaafari N, de la Cruz LF, Grau M, Knowles E, Radua J, Wooderson S, Segalas C, Alonso P, Phillips ML, Menchon JM, Mataix-Cols D.Neurological soft signs in obsessive-compulsive disorder: two empirical studies and meta-analysis. Psychological Medicine 2013; 43:1069-1079. FI: 5.587 Q1.
  • de la Hera B, Varade J, Garcia-Montojo M, Lamas JR, de la Encarnacion A, Arroyo R, Fernandez-Gutierrez B, Alvarez-Lafuente R, Urcelay E. Role of the Human Endogenous Retrovirus HERV-K18 in Autoimmune Disease Susceptibility: Study in the Spanish Population and Meta-Analysis. Plos One 2013; 8: e62090. FI: 3.730 Q1.
  • Matute C, Domercq M, Pérez-Samartín A, Ransom BR. Protecting White Matter From Stroke Injury. Stroke 2013; 44:1204-1211 FI: 6.158 Q1.
  • Bombin I, Mayoral M, Castro-Fornieles J, Gonzalez-Pinto A, de la Serna E, Rapado-Castro M, Barbeito S, Parellada M, Baeza I, Graell M, Payá B, Arango C. Neuropsychological evidence for abnormal neurodevelopment associated with early-onset psychoses. Psychological Medicine 2013; 43:757-768 FI: 5.587 Q1.
  • Toma C, Hervás A, Torrico B, Balmaña N, Salgado M, Maristany M, Vilella E, Martínez-Leal R, Planelles MI, Cuscó I, del Campo M, Pérez-Jurado LA, Caballero-Andaluz R, de Diego-Otero Y, Pérez-Costillas L, Ramos-Quiroga JA, Ribasés M, Bayés M, Cormand B.Analysis of two language-related genes in autism: a case-control association study of FOXP2 and CNTNAP2. Psychiatric Genetics 2013; 23:82-85 FI: 2.365 Q3.
  • Peciña M, Mickey BJ, Love T, Wang H, Langenecker SA, Hodgkinson C, Shen PH, Villafuerte S, Hsu D, Weisenbach SL, Stohler CS, Goldman D, Zubieta JK. DRD2 polymorphisms modulate reward and emotion processing, dopamine neurotransmission and openness to experience. Cortex 2013; 49:877-890 FI: 6.161 Q1.
  • Forn C, Rocca MA, Boscá I, Casanova B, Sanjuan A, Filippi M. Analysis of «task-positive» and «task-negative» functional networks during the performance of the Symbol Digit Modalities Test in patients at presentation with clinically isolated syndrome suggestive of multiple sclerosis. Experimental Brain Research 2013; 225:399-407 FI: 2.221 Q3.
  • Conde V, Palomar FJ, Lama MJ, Martínez R, Carrillo F, Pintado E, Mir P. Abnormal GABA-mediated and cerebellar inhibition in women with the fragile X premutation. Journal of Neurophysiology 2013; 109:1315-1322    FI: 3.301 Q2.
  • Palomar FJ, Suárez A, Franco E, Carrillo F, Gil-Néciga E, Mir P. Abnormal sensorimotor plasticity in CADASIL correlates with neuropsychological impairment. Journal of Neurology Neurosurgery and Psychiatry 2013; 84:329-336 FI: 4.924 Q1.
  • Martinez-Ferré A, Navarro-Garberi M, Bueno C, Martínez S. Wnt Signal Specifies the Intrathalamic Limit and Its Organizer Properties by Regulating Shh Induction in the Alar Plate. Journal of Neuroscience 2013; 33:3967-3980 FI: 6.908 Q1.
  • Linares LO, Martinez-Martin N, Castellanos FX. Stimulant and Atypical Antipsychotic Medications For Children Placed in Foster Homes. Plos One 2013; 8:e54152 FI: 3.730 Q1.
  • Garcia-Montojo M, Varade J, Villafuertes E, de La Hera B, Hoyas-Fernandez J, Domínguez-Mozo MI, Rodriguez-Rodriguez L, Tornero-Esteban P, Arias-Leal A, León L, Lamas JR, Alvarez-Lafuente R, Urcelay E, Fernandez-Gutierrez B. Expression of human endogenous retrovirus HERV-K18 is associated with clinical severity in osteoarthritis patients. Scandinavian Journal of Rheumatology 2013; 42:498-504 FI: 2.216 Q3.
  • Pilar-Cuéllar F, Vidal R, Díaz A, Castro E, dos Anjos S, Pascual-Brazo J, Linge R, Vargas V, Blanco H, Martínez-Villayandre B, Pazos Á, Valdizán EM. Neural Plasticity and Proliferation in the Generation of Antidepressant Effects: Hippocampal Implication. Neural Plasticity 2013; 0.1155/2013/537265  FI: 2.864 Q3.
  • Aznar Casanova JA, Amador Campos JA, Moreno Sánchez M, Supér H. Onset time of binocular rivalry and duration of inter-dominance periods as psychophysical markers of ADHD. Perception 2013; 42:16-27 FI: 1.311 Q3.
  • Sanchez-Gistau V, Baeza I, Arango C, González-Pinto A, de la Serna E, Parellada M, Graell M, Paya B, Llorente C, Castro-Fornieles J. Predictors of Suicide Attempt in Early-Onset, First-Episode Psychoses: A Longitudinal 24-Month Follow-Up Study. Journal of Clinical Psychyatry 2013; 74:61-68 FI: 5.812 Q1.
  • Jesús S, Cáceres-Redondo MT, Carrillo F, Cordones I, Escudero M, Macías-Vidal J, Coll MJ, Bautista J, Mir P. Adult form of Niemann-Pick type C with the variant biochemical phenotype on treatment with Miglustat. Parkinsonism and Related Disorders 2013; 19:916-917  FI: 3.274 Q2.
  • Montes JM, Alegria A, Garcia-Lopez A, Ezquiaga E, Balanzá-Martínez V, Sierra P, Toledo F, Alcaraz C, Perez J, de Dios C. Understanding bipolar disorder in late life: clinical and treatment correlates of a sample of elderly outpatients. The Journal of Nervous and Mental Disease 2013; 201:674-679 FI: 2.292 Q3.
  • Bourne C, Aydemir Ö, Balanzá-Martínez V, Bora E, Brissos S, Cavanagh JT, Clark L, Cubukcuoglu Z, Dias VV, Dittmann S, Ferrier IN, Fleck DE, Frangou S, Gallagher P, Jones L, Kieseppä T, Martínez-Aran A, Melle I, Moore PB, Mur M, Pfennig A, Raust A, Senturk V, Simonsen C, Smith DJ, Bio DS, Soeiro-de-Souza MG, Stoddart SD, Sundet K, Szöke A, Thompson JM, Torrent C, Zalla T, Craddock N, Andreassen OA, Leboyer M, Vieta E, Bauer M, Worhunsky PD, Tzagarakis C, Rogers RD, Geddes JR, Goodwin GM. Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatrica Scandinavica 2013; 128:149-162 FI: 4.857 Q1.
  • Tabarés-Seisdedos R, Rubenstein JL. Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders. Nature Reviews. Neuroscience 2013; 14:293-304 FI: 31.673 Q1.
  • Carballo JJ, García-Nieto R, Pérez-Rodríguez MM, López-Castromán J, Blasco-Fontecilla H, Mata-Iturralde L, de Leon V, Baca-García E. Longitudinal trends in diagnosis at child and adolescent mental health centres in Madrid, Spain. European Child & Adolescent Psychiatry 2013; 22:47-49 FI: 3.699 Q1.
  • Pina-Camacho L, Villero S, Boada L, Fraguas D, Janssen J, Mayoral M, Llorente C, Arango C, Parellada M. Structural magnetic resonance imaging data do not help support DSM-5 autism spectrum disorder category. Research in Autism Spectrum Disorders 2013; 7:333-343 FI: 2.907 Q2.
  • Amador-Campos JA, Aznar-Casanova JA, Moreno-Sánchez M, Medina-Peña A, Ortiz-Guerra JJ. Psychometric properties of a test for ADHD based on Binocular Rivalry. Spanish Journal of Psychology 2013; 16:1-8 FI: 0.827 Q3.
  • Del Pino I, García-Frigola C, Dehorter N, Brotons-Mas JR, Alvarez-Salvado E, Martínez de Lagrán M, Ciceri G, Gabaldón MV, Moratal D, Dierssen M, Canals S, Marín O, Rico B. Erbb4 deletion from Fast-Spiking interneurons causes Schizophrenia-like Phenotypes. Neuron 2013; 79:1152-1168 FI: 15.766 Q1.
  • Alvarez-Segura M, Castellanos FX, Catapano P, Guedeney A. Screening for sustained social withdrawal behaviors in six-month-old infants during pediatric primary care visits: results from an at-risk latino inmigrant sample with high rates of maternal major depressive disorder. Infant Mental Health Journal 2013; 34:542-552.
  • Sánchez-Ramón S., Butnaru D. Modelos de reconocimiento inmunológico: tolerancia e inmunidad en el marco de la evolución del conocimiento científico. Inmunología 2013; 32:139-147.
  • Carrasco P, Jacas J, Sahún I, Muley H, Ramírez S, Puisac B, Mezquita P, Pié J, Dierssen M, Casals N. Carnitine palmitoyltransferase 1C deficiency causes motor impairment and hypoactivity. Behav Brain Res. 2013 Nov 1;256:291-7 FI: 3.391 Q1.
  • Pons-Espinal M, Martinez de Lagran M, Dierssen M. Environmental enrichment rescues DYRK1A activity and hippocampal adult neurogenesis in TgDyrk1A. Neurobiol Dis. 2013 Dec;60:18-31 FI: 5.202 Q1.
en_GBEnglish (UK)
es_ESEspañol en_GBEnglish (UK)